Quick Links
  • ASMS


  • CMSS


  • TSMS




Home>About CASMS> Public Relations and Fund Raising

The Public Relation and Fund Raising Committee

  • Co-Chair:Naidong Weng

    Dr. Weng is Scientific Director, Janssen Fellow, and Head of Bioanalytical Chemistry and Pharmacokinetics, Discovery Sciences, Janssen Research & Development, Johnson and Johnson, Spring House, PA, USA. Currently he supervises a department which has end to end responsibilities

    for LC-MS bioanalysis (discovery and development). The research interests of his group include LC-MS bioanalysis of drug candidates, metabolites, biomarkers, conjugated proteins/peptides, oligonucleotides, and more recently metabolomics. Dr. Weng has over 110 peer-reviewed journal publications and book chapters. He co-edited two books on bioanalysis (Eliminating bottlenecks for efficient bioanalysis: practices and applications in drug discovery and development, 2014; Targeted biomarker quantitation by LC-MS, 2017) and one Special Focus Issue of Bioanalysis on Bioanalytical Laboratory Structure and Management (2014). He has been teaching short courses on DMPK at ASMS since 2011. He is the current US regional editor for Biomedical Chromatography (Wiley).

    More >>
  • Co-Chair:Junmin Peng

    Dr. Junmin Peng is a Member (Professor) in the Departments of Structural Biology and Developmental Neurobiology, and Director of Center for Proteomics and Metabolomics at St. Jude Children’s Research Hospital, a leading institute treating childhood cancer and other life-threatening

    diseases in Memphis. He is interested in developing mass spectrometry-based proteomics, metabolomics and systems biology approaches, and applying these approaches to basic and clinical studies. He obtained his B.S. at Wuhan University in 1991, and his Ph.D. at the University of Iowa, where he cloned the transcription elongation factor P-TEFb (CDK9/cyclin T) under the guidance of Dr. David Price. He then received postdoctoral training at Harvard as a Jane Coffin Childs Fellow in Neuroscience (mentor: Dr. Li-Huei Tsai) and Proteomics (mentor: Dr. Steven Gygi). In 2002 he joined the faculty at Emory University and moved to St. Jude in 2011. Dr. Peng contributes to establishing target-decoy strategies, profiling ubiquitinated proteome and synaptic proteome, identifying complex ubiquitin code, and discovering RNA splicing dysfunction in Alzheimer’s disease. He has published 180+ scientific papers (22,000+ citations in Google Scholar), including publications in Cell, Nature, Science, Nature Biotechnology, and Nature Neuroscience. He has been invited to present 80+ seminars and has trained 60+ scientists. His studies provide novel insights into disease pathogenesis for therapeutic intervention, and may reveal novel biomarkers for precision medicine.

    More >>
Level of Sponsorship

Diamond Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Media Sponsors